| Display title | Biology:Vaborbactam |
| Default sort key | Vaborbactam |
| Page length (in bytes) | 9,549 |
| Namespace ID | 3026 |
| Namespace | Biology |
| Page ID | 413014 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>TextAI2 |
| Date of page creation | 18:56, 11 February 2024 |
| Latest editor | imported>TextAI2 |
| Date of latest edit | 18:56, 11 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Vaborbactam (INN) is a non-β-lactam β-lactamase inhibitor discovered by Rempex Pharmaceuticals, a subsidiary of The Medicines Company. While not effective as an antibiotic by itself, it restores potency to existing antibiotics by inhibiting the β-lactamase enzymes that would otherwise degrade them. When... |
